Detailed Cognitive Function and Use of Drugs with Anticholinergic Properties in Older People
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Many potentially inappropriate drugs prescribed to older people have anticholinergic properties and may therefore be harmful. Drugs with anticholinergic properties (DAPs) are associated with cognitive decline.
Our aim was to study the profile of various cognitive functions related to current use of DAPs.
A cross-sectional study was conducted in Helsinki, Finland, and included 400 home-dwelling individuals aged 75–90 years without major clinical dementia but with a history of stable atherosclerotic disease who were participants of the DEBATE (Drugs and Evidence-Based Medicine in the Elderly) study. The cognition of the users (n = 295) and non-users (n = 105) of DAPs was measured with the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) test battery.
Use of DAPs was statistically significantly associated with a low score in verbal fluency, in naming, and on the Mini-Mental State Examination (MMSE). In the logistic regression analysis, the difference remained for low verbal fluency (odds ratio [OR] 1.84, 95 % CI 1.02–3.32; p = 0.044) and naming (OR 1.81, 95 % CI 1.09–3.00; p = 0.021) but not for MMSE score after adjusting for age, sex and education.
Performances for verbal fluency and naming were poorer in DAP users than in non-users, suggesting a possible impairment of executive functioning and semantic memory. The dimensions of the CERAD test assessing episodic memory—the subtests that are the most sensitive in terms of detecting early Alzheimer’s disease—did not show differences between users and non-users of DAPs.
- Ott A, Bertelera MM, van Harskamp F, et al. Prevalence of Alzheimer’s disease and vascular dementia: association with education. The Rotterdam study. BMJ. 1995;310(6985):970–3. CrossRef
- Pitkälä KH, Strandberg TE, Tilvis RS. Is it possible to reduce polypharmacy in the elderly? Drugs Aging. 2001;18(2):143–9. CrossRef
- Lechevallier-Michel N, Molimard M, Dartigues JF, et al. Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID study. Br J Clin Pharmacol. 2005;59(2):143–51. CrossRef
- Ancelin M, Artero S, Portet F, et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ. 2006;332(7539):455–9. CrossRef
- Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345–51. CrossRef
- Tune L, Carr S, Hoag E, et al. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. Am J Psychiatry. 1992;149(10):1393–4.
- Uusvaara J, Pitkala KH, Tienari PJ, et al. Association between anticholinergic drugs and apolipoprotein E ε4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study. J Am Geriatr Soc. 2009;57(3):427–31. CrossRef
- Carrière I, Fourrier-Reglat A, Dartigues JF, et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med. 2009;169(14):1317–24. CrossRef
- Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer’s disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology. 1989;39(9):1159–65. CrossRef
- Sotaniemi M, Pulliainen V, Hokkanen L, et al. CERAD-neuropsychological battery in screening mild Alzheimer’s disease. Acta Neurol Scand. 2012;125:16–23. CrossRef
- Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98. CrossRef
- Mulsant BH, Pollock BG, Kirshner M, et al. Serum anticholinergic activity in a community-based sample of older adults. Arch Gen Psychiatry. 2003;60:198–203. CrossRef
- Brébion G, Bressan RA, Amador X, et al. Medications and verbal memory impairment in schizophrenia: the role of anticholinergic drugs. Psychol Med. 2004;34(2):369–74. CrossRef
- Bottiggi KA, Salazar JC, Yu L, et al. Long-term cognitive impact of anticholinergic medications in older adults. Am J Geriatr Psychiatry. 2006;14(11):980–4. CrossRef
- Cao YJ, Mager DE, Simonsick EM, et al. Physical and cognitive performance and burden of anticholinergics, sedatives and ACE inhibitors in older women. Clin Pharmacol Ther. 2008;83(3):422–9. CrossRef
- Han L, Agostini JV, Allore HG. Cumulative anticholinergic exposure is associated with poor memory and executive function in older men. J Am Geriatr Soc. 2008;56(12):2203–10. CrossRef
- Cancelli I, Gigli GL, Piani A, et al. Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population-based study. J Clin Psychopharmacol. 2008;28(6):654–9. CrossRef
- Campbell N, Boustani M, Limbil T, et al. The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging. 2009;4:225–33.
- Strandberg TE, Pitkala KH, Berglind S, et al. Multifactorial cardiovascular disease prevention in patients aged 75 and older: a randomized controlled trial: Drugs and Evidence Based Treatment in the Elderly (DEBATE) Study. Am Heart J. 2001;142(2):945–51. CrossRef
- Strandberg TE, Pitkala KH, Berglind S, et al. Possibilities of multifactorial cardiovascular disease prevention in patients aged 75 and older: a randomized, controlled trial. Drugs and Evidence-Based Treatment in the Elderly (DEBATE) Study. Eur Heart J. 2003;24(13):1216–22. CrossRef
- Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 1991;337(8750):1158–9. CrossRef
- Graham NL, Emery T, Hodges JR. Distinctive cognitive profiles in Alzheimer’s disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry. 2004;75(1):61–71.
- Salthouse TA. Relations between cognitive abilities and measures of executive functioning. Neuropsychology. 2005;19(4):532–45. CrossRef
- Bentham PW, Jones S, Hodges JR. A comparison of semantic memory in vascular dementia and dementia of Alzheimer’s type. Int J Geriatr Psychiatry. 1997;12(5):575–80. CrossRef
- Mack WJ, Freed DM, Williams BW, et al. Boston Naming Test: shortened versions for use in Alzheimer’s disease. J Gerontol. 1992;47(3):154–8. CrossRef
- Vogel A, Gade A, Stokholm J, Waldemar G. Semantic memory impairment in the earliest phases of Alzheimer’s disease. Dement Geriatr Cogn Disord. 2005;19(2–3):75–81. CrossRef
- Greene JD, Baddley AD, Hodges JR. Analysis of the episodic memory deficit in early Alzheimer’s disease: evidence from the doors and people test. Neuropsychologia. 1996;34(6):537–51. CrossRef
- Budson AE, Wolk DA, Chong H, et al. Episodic memory in Alzheimer’s disease: separating response bias from discrimination. Neuropsychologia. 2006;44(12):2222–32. CrossRef
- Ravens J. Vascular changes in human senile brain. Adv Neurol. 1978;20:487–501.
- Abbott N, Rönnbäck L, Hansson E. Astrocyte-endothelial interactions at the blood–brain barrier. Nat Rev Neurosci. 2006;7(1):41–53. CrossRef
- Mintzer J, Burns A. Anticholinergic side-effects of drugs in elderly people. J R Soc Med. 2000;93:457–62.
- Beers MH, Ouslander JG, Rollinger I, et al. Explicit criteria for determining potentially inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151:1825–32. CrossRef
- Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arc Intern Med. 1997;157:1531–6. CrossRef
- Chutka D, Takahashi P, Hoel R. Inappropriate medications for elderly patients. Mayo Clin Proc. 2004;79:122–39. CrossRef
- Herbison P, Hay-Smith J, Ellis G, et al. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ. 2003;326:841–4. CrossRef
- Liu H, Farley J. Effects of first and second generation antihistamines on muscarinic induced mucus gland cell ion transport. BMC Pharmacol. 2005;5:8. CrossRef
- DeMaagd G, Geibig J. An overview of overactive bladder and its pharmacological management with a focus on anticholinergic drugs. P&T. 2006;31:462–71.
- Seale P. Anticholinergic bronchodilatators. Aust Prescr. 2003;26:33–5.
- Tandon R, Taylor S, Quardo J, et al. The cholinergic system in schizophrenia reconsidered: anticholinergic modulation of sleep and symptom profiles. Neuropsychopharmacology. 1999;21:189–202. CrossRef
- Shiraishi M, Minami K, Uezono Y, et al. Inhibition by tramadol of muscarinic receptor-induced responses in cultured adrenal medullary cells and in xenopus laevis oocytes. JPET. 2001;299:255–60.
- Saito M, Shibata O, Yamaguchi M, et al. Metoclopramide causes airway smooth muscle relaxation through inhibition of muscarinic M3 receptor in the rat trachea. Anesth Analg. 2004;98:325–9.
- Isah A, Rawlins M, Bateman D. The pharmacokinetics and effects of prochlorperazine in elderly female volunteers. Oxf J. 1991;21:27–31.
- Kay G, Abou-Donia M, Messer W, et al. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients. JAGS. 2005;53:2195–201. CrossRef
- Cechin EM, Quevedo J, Barichello T, et al. Dose-related effects of propericiazine in rats. Braz J Med Biol Res. 2003;36:227–31. CrossRef
- Minami K, Yasuhito U, Yoichi U. Pharmacological aspects of the effects of tramadol on G-protein coupled receptors. J Pharmacol Sci. 2007;103:253–60. CrossRef
- Detailed Cognitive Function and Use of Drugs with Anticholinergic Properties in Older People
Drugs & Aging
Volume 30, Issue 3 , pp 177-182
- Cover Date
- Print ISSN
- Online ISSN
- Springer International Publishing AG
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Unit of Primary Health Care, Helsinki University Central Hospital, Helsinki, Finland
- 2. Department of General Practice and Primary Health Care, University of Helsinki, Helsinki, Finland
- 3. Kauniala Hospital for Disabled War Veterans, Kylpyläntie 19, 02700, Kauniainen, Finland
- 4. Unit of General Internal Medicine and Geriatrics, Helsinki University Hospital, Helsinki, Finland
- 5. Department of Medicine, Geriatric Clinic, University of Helsinki and University Hospital, Helsinki, Finland
- 6. Institute of Health Sciences/Geriatrics, University Hospital and Health Center of Oulu, Oulu, Finland